The clinical class of CLL is rather heterogeneous, starting from a fairly asymptomatic disease that may even regress spontaneously to the progressive ailment that sooner or later results in the affected individual’s death, so there has constantly been remarkable desire in figuring out the prognosis of individual patients. Though a lot of prognost